Paul Hastings Advises GENUI on Sale of and Reinvestment in VALEARA Group
Frankfurt – Paul Hastings (Europe) LLP advised private investment firm GENUI and other minority shareholders on the sale of VALEARA Group to Luxempart S.A. The firm also advised on GENUI's reinvestment (alongside other minority shareholders) of a significant amount of the sale proceeds into Valeara.
A private investment firm based in Germany and Switzerland, GENUI focuses on investments in the health, environmental transformation and digitalization sectors. Valeara is a leading provider of ambulatory mental healthcare services and Luxempart is a Luxembourg-based listed investment company with a net worth of €2.3 billion backed by Luxembourgish entrepreneurial families.
Private Equity and M&A partner Dr. Christopher Wolff led the Paul Hastings team, which also included partners Dr. Melchior Raiser (Finance) and Dr. Jan Gernoth (Real Estate); associates Julian Schmitz, Mahmood Kawany, Carl Kostelezky, Dr. Faraz Maneshkarimy (Private Equity/M&A), Dr. Johanna Mayer-Ismail (Real Estate) and Dr. Johannes Hilpert (Finance); and tax advisor Uwe Halbig.
With widely recognized elite teams across 18 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world's leading investment banks, asset managers and corporations.